The latest closing stock price for TScan Therapeutics as of April 28, 2025 is 1.60.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-848 today, roughly -1 times their original investment - a -37.52% compound annual growth rate over 4 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.69, which is 505.6% above the current share price.
The TScan Therapeutics 52-week low stock price is 1.02, which is 36.3% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 4.70.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-848 today, roughly -1 times their original investment - a -37.52% compound annual growth rate over 4 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.69, which is 505.6% above the current share price.
The TScan Therapeutics 52-week low stock price is 1.02, which is 36.3% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 4.70.